Ibnsina Pharma (EGX:ISPH)

Egypt · Delayed Price · Currency is EGP

12.51

+0.36 (2.96%)

At close: Jun 4, 2026

Revenue by Segment

Financials in millions EGP. Fiscal year is January - December.

Millions EGP. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Wholesale - Drugs	76.60B	55.84B	33.95B	22.26B	21.73B
Wholesale - Drugs Growth	37.17%	64.49%	52.48%	2.45%	16.35%
Total	76.60B	55.84B	33.95B	22.26B	21.73B
Total Growth	37.17%	64.49%	52.48%	2.45%	16.35%

Revenue by Geography

Financials in millions EGP. Fiscal year is January - December.

Millions EGP. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Egypt	76.60B	55.84B	33.95B	22.26B	21.73B
Egypt Growth	37.17%	64.49%	52.48%	2.45%	16.35%
Total	76.60B	55.84B	33.95B	22.26B	21.73B
Total Growth	37.17%	64.49%	52.48%	2.45%	16.35%

Source: S&P Global Market Intelligence.